It promotes tumor progression by directly suppressing phosphatase and tensin homolog (PTEN) and cyclin-dependent kinase inhibitor 1A (CDKN1A), thereby enhancing c-Met/PI3K/Akt signaling. The gene discussed is PTEN; the disease is neoplasm.